Synthetic Review

Synthetic engineering is going to outdo genetic engineering, predicts this Week in Review article from the New York Times. Right now, the field is in its infancy and is merely copying life rather than creating it from scratch, says the article, but a major potential application is bioenergy -- and a major concern is bioterrorism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.